ExpreS2ion Biotech Holding AB has a quick ratio of 1.87. It generally indicates good short-term financial strength.
The historical rank and industry rank for ExpreS2ion Biotech Holding AB's Quick Ratio or its related term are showing as below:
FRA:5JD0'
s Quick Ratio Range Over the Past 10 Years
Min: 0.83 Med: 3.29 Max: 26.96
Current: 1.87
During the past 13 years, ExpreS2ion Biotech Holding AB's highest Quick Ratio was 26.96. The lowest was 0.83. And the median was 3.29.
FRA:5JD0's Quick Ratio is ranked worse than 67.14% of 1412
companies
in the Biotechnology industry
Industry Median: 3.6
vs FRA:5JD0: 1.87
ExpreS2ion Biotech Holding AB (FRA:5JD0) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
ExpreS2ion Biotech Holding AB Quick Ratio Related Terms
ExpreS2ion Biotech Holding AB Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5JD0 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ExpreS2ion Biotech Holding AB Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's Quick Ratio distribution charts can be found below:
* The bar in red indicates where ExpreS2ion Biotech Holding AB's Quick Ratio falls into.
ExpreS2ion Biotech Holding AB Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ExpreS2ion Biotech Holding AB (FRA:5JD0) has a Quick Ratio of 1.87 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ExpreS2ion Biotech Holding AB and its competitors. This is 43% below median its historical median of 3.29. Over the past decade, ExpreS2ion Biotech Holding AB's Quick Ratio has ranged from 0.83 to 26.96. According to the industry distribution chart, ExpreS2ion Biotech Holding AB ranks #948 out of 1412 companies in the Biotechnology industry, placing it in the top 67.1%.
Is ExpreS2ion Biotech Holding AB's Quick Ratio too high?
ExpreS2ion Biotech Holding AB's current Quick Ratio of 1.87 is 43% below median its 10-year median of 3.29. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 26.96. The Biotechnology industry median Quick Ratio is 3.60. ExpreS2ion Biotech Holding AB's value of 1.87 is 48.1% below this industry median. Based on the distribution chart, ExpreS2ion Biotech Holding AB ranks #948 out of 1412 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ExpreS2ion Biotech Holding AB has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does ExpreS2ion Biotech Holding AB's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ExpreS2ion Biotech Holding AB ranks #948 out of 1412 companies for Quick Ratio. This places ExpreS2ion Biotech Holding AB in the lower half of its industry. The industry median Quick Ratio is 3.60. ExpreS2ion Biotech Holding AB's value of 1.87 is 48.1% below this benchmark. Historically, ExpreS2ion Biotech Holding AB's own Quick Ratio has ranged from 0.83 to 26.96 over the past decade. While the company's 10-year median is 3.29 vs. the industry median of 3.60, ExpreS2ion Biotech Holding AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ExpreS2ion Biotech Holding AB's current Quick Ratio of 1.87 is 48.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ExpreS2ion Biotech Holding AB and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ExpreS2ion Biotech Holding AB's current Quick Ratio is 1.87, which is 43% below median its own 10-year median of 3.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ExpreS2ion Biotech Holding AB stock overvalued right now?
ExpreS2ion Biotech Holding AB (FRA:5JD0) has a current Quick Ratio of 1.87. The stock's GF Value™ is €0.09, compared to a current price of €0.03 — trading 68.2% below its estimated fair value. The current Quick Ratio is 1.87, which is 43% below median its 10-year median of 3.29 and 48.1% below the Biotechnology industry median of 3.60. ExpreS2ion Biotech Holding AB's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For ExpreS2ion Biotech Holding AB (FRA:5JD0), the current Quick Ratio is 1.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ExpreS2ion Biotech Holding AB (FRA:5JD0) Overvalued in 2026?
Based on GuruFocus' analysis, ExpreS2ion Biotech Holding AB stock appears to be undervalued.
The current stock price of €0.03 is trading 68.2% below its estimated GF Value™ of €0.09.
Key valuation signals for FRA:5JD0:
Quick Ratio: 1.87 (43% below median its 10-year median of 3.29)
GF Value™: €0.09 vs. price of €0.03 (68.2% below fair value)
Industry Position: 48.1% below the Biotechnology median (#948 of 1412)
No single metric tells the full story. See the FRA:5JD0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ExpreS2ion Biotech Holding AB Business Description
ExpreS2ion Biotech Holding AB is a biotechnology company that develops vaccines. It has developed a human clinical Phase III-validated technology platform, ExpreS2, for fast and efficient development and production of the active material in vaccines. The platform, under the brand GlycoX-S2, includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. Its product pipeline comprises ES2B-C001, a HER2-VLP-based vaccine in development for human breast cancer therapy and several exploratory vaccine projects targeting pathways validated by commercial monoclonal antibody products. Geographically, the company operates in the Nordics region and also has a presence in other countries.
43GF Score
Get the complete analysis for FRA:5JD0
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5JD0 has been successfully added to your 
